Cytomegalovirus in Transplantation: Developing Drugs to Treat or Prevent Disease
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 21, 2018
May 7, 2020
070d95a8-6704-4190-b2d6-8b1e6b7a5a2e
Related Documents
Anthrax: Developing Drugs for Prophylaxis of Inhalational Anthrax Guidance for Industry
Guidance DocumentMay 24, 2018Center for Drug Evaluation and Research
Vulvovaginal Candidiasis: Developing Drugs for Treatment
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment
Guidance DocumentJanuary 10, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.